Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 28


Plague: Infections of Companion Animals and Opportunities for Intervention.

Oyston PC, Williamson D.

Animals (Basel). 2011 Jun 21;1(2):242-55. doi: 10.3390/ani1020242. Review.


Plague vaccines: current developments and future perspectives.

Feodorova VA, Motin VL.

Emerg Microbes Infect. 2012 Nov;1(11):e36. doi: 10.1038/emi.2012.34. Epub 2012 Nov 7. Review.


Selective Protective Potency of Yersinia pestis ΔnlpD Mutants.

Dentovskaya SV, Ivanov SA, Kopylov PKh, Shaikhutdinova RZ, Platonov ME, Kombarova TI, Gapel'chenkova TV, Balakhonov SV, Anisimov AP.

Acta Naturae. 2015 Jan-Mar;7(1):102-8.


Comparison of virulence between the Yersinia pestis Microtus 201, an avirulent strain to humans, and the vaccine strain EV in rhesus macaques, Macaca mulatta.

Tian G, Qi Z, Qiu Y, Wu X, Zhang Q, Yang X, Xin Y, He J, Bi Y, Wang Q, Zhou J, Fan Y, Zhou Y, Jiang Y, Yang R, Wang X.

Hum Vaccin Immunother. 2014;10(12):3552-60. doi: 10.4161/hv.35119.


LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.

Sun W, Sanapala S, Henderson JC, Sam S, Olinzock J, Trent MS, Curtiss R 3rd.

Infect Immun. 2014 Oct;82(10):4390-404. doi: 10.1128/IAI.02173-14. Epub 2014 Aug 11.


Rational considerations about development of live attenuated Yersinia pestis vaccines.

Sun W, Curtiss R.

Curr Pharm Biotechnol. 2013;14(10):878-86. Review.


Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques.

Zhang Q, Wang Q, Tian G, Qi Z, Zhang X, Wu X, Qiu Y, Bi Y, Yang X, Xin Y, He J, Zhou J, Zeng L, Yang R, Wang X.

Hum Vaccin Immunother. 2014;10(2):368-77. doi: 10.4161/hv.27060. Epub 2013 Nov 13.


Polymorphisms in the lcrV gene of Yersinia enterocolitica and their effect on plague protective immunity.

Miller NC, Quenee LE, Elli D, Ciletti NA, Schneewind O.

Infect Immun. 2012 Apr;80(4):1572-82. doi: 10.1128/IAI.05637-11. Epub 2012 Jan 17.


The role of immune correlates and surrogate markers in the development of vaccines and immunotherapies for plague.

Williamson ED.

Adv Prev Med. 2012;2012:365980. doi: 10.1155/2012/365980. Epub 2011 Sep 29.


Developing live vaccines against plague.

Sun W, Roland KL, Curtiss R 3rd.

J Infect Dev Ctries. 2011 Sep 14;5(9):614-27. Review.


Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines.

Quenee LE, Ciletti NA, Elli D, Hermanas TM, Schneewind O.

Vaccine. 2011 Sep 2;29(38):6572-83. doi: 10.1016/j.vaccine.2011.06.119. Epub 2011 Jul 16.


Model systems to study plague pathogenesis and develop new therapeutics.

Lawrenz MB.

Front Microbiol. 2010 Nov 4;1:119. doi: 10.3389/fmicb.2010.00119. eCollection 2010.


Plague in Guinea pigs and its prevention by subunit vaccines.

Quenee LE, Ciletti N, Berube B, Krausz T, Elli D, Hermanas T, Schneewind O.

Am J Pathol. 2011 Apr;178(4):1689-700. doi: 10.1016/j.ajpath.2010.12.028. Epub 2011 Mar 4.


Levofloxacin cures experimental pneumonic plague in African green monkeys.

Layton RC, Mega W, McDonald JD, Brasel TL, Barr EB, Gigliotti AP, Koster F.

PLoS Negl Trop Dis. 2011 Feb 8;5(2):e959. doi: 10.1371/journal.pntd.0000959.


A live attenuated strain of Yersinia pestis KIM as a vaccine against plague.

Sun W, Six D, Kuang X, Roland KL, Raetz CR, Curtiss R 3rd.

Vaccine. 2011 Apr 5;29(16):2986-98. doi: 10.1016/j.vaccine.2011.01.099. Epub 2011 Feb 12. Erratum in: Vaccine. 2011 Aug 5;29(34):5820.


Role of purine biosynthesis in Bacillus anthracis pathogenesis and virulence.

Jenkins A, Cote C, Twenhafel N, Merkel T, Bozue J, Welkos S.

Infect Immun. 2011 Jan;79(1):153-66. doi: 10.1128/IAI.00925-10. Epub 2010 Nov 1.


Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation.

Layton RC, Brasel T, Gigliotti A, Barr E, Storch S, Myers L, Hobbs C, Koster F.

J Med Primatol. 2011 Feb;40(1):6-17. doi: 10.1111/j.1600-0684.2010.00443.x. Epub 2010 Aug 16.


Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV-cholera toxin A(2)/B chimeras.

Tinker JK, Davis CT, Arlian BM.

Protein Expr Purif. 2010 Nov;74(1):16-23. doi: 10.1016/j.pep.2010.04.021. Epub 2010 May 11.


Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.

Sun W, Roland KL, Kuang X, Branger CG, Curtiss R 3rd.

Infect Immun. 2010 Mar;78(3):1304-13. doi: 10.1128/IAI.01122-09. Epub 2010 Jan 19.


Clinical and pathologic features of cynomolgus macaques (Macaca fascicularis) infected with aerosolized Yersinia pestis.

Van Andel R, Sherwood R, Gennings C, Lyons CR, Hutt J, Gigliotti A, Barr E.

Comp Med. 2008 Feb;58(1):68-75.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk